Methods for use of OMP26 from Haemophilus influenzae
US6254875A · kind A · utility
2Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 1999 |
| Grant date | Jul 3, 2001 |
| Priority date | — |
| Expiry date | May 13, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel antigenic protein derived from the outer membrane of H. influenzae is provided. DNA sequences encoding such a protein are also provided as are vaccines comprising the protein and methods of immunizing a subject against H. influenzae infection. The invention also includes methods for the prophylaxis or treatment of respiratory tract infections or otitis media, as well as methods for the detection of H. influenzae, and kits for use in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.